The company
BillionToOne, Inc.
BLLN · Nasdaq
BLLN stood above a rising 150-day average in 11 of the last 14 weekly readings, including each of the last 1 week. It is 1.4% above that average now. Diagnostics & Labs: 50% of its 44 stocks in an uptrend (+2 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 1 in a row
- Industry in uptrend
- 50% +2 in 4 wk
- Insider buys, 12 months
- $3.2M
- Insider sales, 12 months
- $97.3M
- Officials’ trades on record
- 0
- Institutions holding
- 150 (+63)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 11 of 14 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Oguzhan AtayChairman and CEO | sold | 900at $98.43 | 15 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 1,861at $99.84 | 15 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 1,276at $100.60 | 15 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 980at $101.79 | 15 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 133at $102.78 | 15 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 3,083at $98.32 | 14 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 100at $99.00 | 14 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 2,667at $98.00 | 14 Oct 2026filed 16 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 1,961at $91.57 | 12 Oct 2026filed 14 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 2,553at $93.05 | 12 Oct 2026filed 14 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 6,763at $93.65 | 12 Oct 2026filed 14 Oct 2026 |
| Oguzhan AtayChairman and CEO | sold | 3,869at $94.61 | 12 Oct 2026filed 14 Oct 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| ADAMS STREET PARTNERS LLCunchanged · filed 14 Aug 2026 | 1,711,430$205.3M | 00.0% |
| BAILLIE GIFFORD & COreduced · filed 6 Aug 2026 | 901,420$108.2M | -358,573−28.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 840,970$100.9M | +689,757+456.1% |
| Invesco Ltd.added · filed 14 Aug 2026 | 835,614$100.3M | +429,102+105.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 799,468$95.9M | +617,005+338.2% |
| NEUBERGER BERMAN GROUP LLCadded · filed 13 Aug 2026 | 764,215$91.7M | +55,001+7.8% |
| BAMCO INCadded · filed 14 Aug 2026 | 742,093$89.0M | +608+0.1% |
| WASATCH ADVISORS LPadded · filed 10 Jul 2026 | 518,084$62.2M | +148,446+40.2% |
| MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 2026 | 425,032$51.0M | +425,032 |
| FULLER & THALER ASSET MANAGEMENT, INC.new · filed 12 Aug 2026 | 418,565$50.2M | +418,565 |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.